Ireland.GW Pharmaceuticals, the AIM-listed developer of the new treatment called Sativex, already sells the product...
The news of the fine came just three months after Elan announced in April 2010 that it was considering
The patient had previously used Tysabri.Mr Clerkin said yesterday that Elan had not liaised with Novartis on the...
The pair are unrelated.The drug company head saw shares at Elan almost double in 2011 on the back of a series of...
Last year, he bagged a pay deal worth €9.3m. He received €2.16m in salary and bonus as well as a mega-share option...
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Chicago, IL – May 21, 2012 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the Full Article at Zacks Investment Research
Alkermes ( ALKS ) reported break-even earnings (including depreciation and stock-based compensation expenses) in the fourth quarter of fiscal 2012 (ended March 31, 2012). The Zacks Consensus Estimate hinted at a loss of $0.15 per share. This was the seco Full Article at NASDAQ
Biogen Idec ( BIIB ) and Elan Corporation, plc ( ELN ) recently announced the publishing of research from the Tysabri risk management program in the New England Journal of Medicine. The research was based on data from Tysabri trials, post-marketing stud Full Article at NASDAQ
Biogen Idec (BIIB - Analyst Report) and Elan Corporation, plc (ELN - Snapshot Report) recently announced the publishing of research from the Tysabri risk management program in the New England Journal of Medicine. The research was based on data from Tysab Full Article at Zacks Investment Research
WESTON, Mass. Full Article at Check Orphan
THE MERGER with Elan Drug Technologies and a strong performance by its portfolio of drugs saw biotech group Alkermes report a more than doubling of revenues for the year to March 31st last. The US-listed group, which moved its headquarters to Ireland fol Full Article at Irish Times
Alkermes PLC said Thursday it took a larger loss in its fiscal fourth quarter after it acquired a drug technology business and took a one-time charge related to research and development. Alkermes took a $45.8 million charge after buying Elan Corp. PLC's Full Article at CNBC
All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. 0 NEW YORK Alkermes PLC said Thursday it took a larger loss in its fiscal fourth quarter after it acquired a drug technology bus Full Article at CBS News
There are no results for this module. Edit this module to change the search term used to query related photos.
There are no results for this module. Edit this module to change the search term used to query Wikipedia
There are no results for this module. Edit the module to change the search term used to query related quotes.
We found no quotes related to Elan Corporation plc.
- DailyMarkets
4 days ago
- jennylinjenny84
4 days ago
- Blake1562
4 days ago
- TradingEditions
5 days ago
Elan Corporation plc and Georgia: The purchase includes Elan's former manufacturing facility in Athlone, where almost 450 people are employed, and another in Gainesville, Georgia.
A fresh, fun site featuring celeb gossip, fashion, beauty, love & sex, and health & fitness.
©Independent.ie Back to top